[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345566-105":59,"doc-detail-345566-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-clinical-assessment-of-mir-34a-and-mir-135b-panel-as-promising-diagnostic-biomarkers-a-case-control-study","The clinical assessment of miR-34a and miR-135b panel as promising diagnostic biomarkers - A case-control study","","The study evaluates whether miR-34a and miR-135b can serve as promising non-invasive diagnostic biomarkers for early colorectal cancer (CRC). It measures miRNA expression in fifteen newly diagnosed CRC cases and matched normal controls using tissue and serum samples, and assesses predictive performance with receiver operating characteristic analysis. CRC tissues show significantly decreased miR-34a and increased miR-135b versus adjacent normal tissue, with similar serum observations. The authors also report increased SIRT-1 and decreased DAPK-1 in CRC tissues, with a high AUC for timely detection, supporting miRNA panel-based CRC risk assessment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-clinical-assessment-of-mir-34a-and-mir-135b-panel-as-promising-diagnostic-biomarkers-a-case-control-study/345566/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-clinical-assessment-of-mir-34a-and-mir-135b-panel-as-promising-diagnostic-biomarkers-a-case-control-study/345566.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of evaluating miR-34a and miR-135b in colorectal cancer?","Question",{"text":112,"@type":113},"The study explores whether the expression levels of miR-34a and miR-135b can act as potential biomarkers for early diagnosis of colorectal cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were miR-34a and miR-135b measured in this case-control study?",{"text":117,"@type":113},"Fifteen newly diagnosed colorectal cancer pairs with normal samples were analyzed for tissue and serum miRNA levels, along with target genes SIRT1 and DAPK-1.",{"name":119,"@type":110,"acceptedAnswer":120},"What differences in miRNA expression and target genes were observed in CRC?",{"text":121,"@type":113},"CRC tissues had significantly downregulated miR-34a and upregulated miR-135b versus adjacent normal tissue. Serum showed similar miRNA changes, with increased SIRT-1 and reduced DAPK-1 in CRC tissues.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345566,1790560739,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","The clinical assessment of miR-34a and miR-135b panel as promising diagnostic biomarkers predict the risk of colorectal cancer: A case-control study  \nCancer Biomarkers Vol. 43(0): 1–9 © The Author(s) 2026 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/18758592261429266](DOI: 10.1177/18758592261429266)[ ](DOI: 10.1177/18758592261429266)[journals.sagepub.com/home/cbm](journals.sagepub.com/home/cbm)  \nRoya Karami 1,\\#, Elaheh Najaﬁ1,\\#, Anahita Babaei2, Erfan Shahdoust2, Ali Shaghaghi3, Nasrin Amiri-Dashatan4, Behrooz Motlagh 1, Mehdi Koushki 1,5  \nand Hadi Khodabandehloo 1   \nAbstract  \nBackground: miRNAs are of interest due to have been involved in cancers such as colorectal cancer (CRC). Objective: To explore the expression levels of miRNA-34a and miRNA-135b and whether they can be potential biomarker for early diagnosis of CRC.  \nMethods: Fifteen pairs newly diagnosed colorectal cancer and normal involved in the measurement of tissue and serum levels of miRNAs 34a and 135b and their target genes of SIRT1 and DAPK-1 . We assessed the predictive value of these miRNAs utilizing the receiver operating characteristic curve.  \nResults: The ﬁndings have shown that the miRNA-34a expression was signiﬁcantly downregulated and miRNA-135b was upregulated in CRC tissues in comparison to their expression in adjacent normal tissue. This was additionally observed in the serum of the same CRC cases when compared to individuals without CRC. Furthermore, we found a signiﬁcant increase in the level of SIRT-1 and a signiﬁcant reduction in the expression level of DAPK-1 in CRC tissues compared to the adjacent normal tissue. The value of AUC was considerably high for the timely detection of CRC. Conclusions: We found these miRNAs acting as potential non-invasive biomarkers for the early detection of CRC and in assessing the CRC risk within the general population.  \nKeywords  \nmicroRNA-34a, microRNA-135b, colorectal cancer, biomarker, target gene  \nReceived: 21 April 2025; accepted: 16 February 2026  \nIntroduction  \nColorectal cancer (CRC) is one of the most prevalent malignant tumors, developing gradually from aberrant crypt foci  \n1 Department of Clinical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran  \n2Department of Medical Laboratory, School of Paramedical Sciences, Zanjan University of Medical Sciences, Zanjan, Iran  \n3Department of General Surgery, School of Medicine, Ayatollah Mousavi Hospital, Zanjan University of Medical Sciences, Zanjan, Iran  \n4Zanjan Metabolic Diseases Research Center, Health and Metabolic Diseases Research Institute, Zanjan University of Medical Sciences, Zanjan, Iran  \n5Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran  \nthrough benign adenomas to malignant adenocarcinomas. 1,2 Despite treatment advances—including surgery, chemotherapy, targeted therapies, immunotherapy, and radiation—the  \n\\#Contributed equally to this work as ﬁrst author.  \nCorresponding authors:  \nHadi Khodabandehloo, Department of Clinical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.  \nEmails: [h.khodabandehloo@gmail.com](h.khodabandehloo@gmail.com); [h.khodabandehloo@zums.ac.ir](h.khodabandehloo@zums.ac.ir)  \nMehdi Koushki, Department of Clinical Biochemistry, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.  \n[Email: mehdikoushki@zums.ac.ir](Email: mehdikoushki@zums.ac.ir)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution  \nNonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as speciﬁed on the SAGE and Open Access pag","cbCaivz3JhXFaIk6","https://ap.wps.com/l/cbCaivz3JhXFaIk6","pdf",585156,"English","# Abstract\n## Background\n## Objective\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the purpose of evaluating miR-34a and miR-135b in colorectal cancer?\",\"answer\":\"The study explores whether the expression levels of miR-34a and miR-135b can act as potential biomarkers for early diagnosis of colorectal cancer.\"},{\"question\":\"How were miR-34a and miR-135b measured in this case-control study?\",\"answer\":\"Fifteen newly diagnosed colorectal cancer pairs with normal samples were analyzed for tissue and serum miRNA levels, along with target genes SIRT1 and DAPK-1.\"},{\"question\":\"What differences in miRNA expression and target genes were observed in CRC?\",\"answer\":\"CRC tissues had significantly downregulated miR-34a and upregulated miR-135b versus adjacent normal tissue. Serum showed similar miRNA changes, with increased SIRT-1 and reduced DAPK-1 in CRC tissues.\"}]","The clinical assessment of miR-34a and miR-135b panel as promising diagnostic biomarkers - A case-control study | PDF",1790058102,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e78f6f9f09689a3ee7a10771065d3fe5.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd00de67a331ee27f827c68b5e1309dd.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/526eebfe34163ecdeb0c7c078ba6d61e.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6dda4d44925a74201d97cc90b8de5cde.webp",980,1306]